Tyers Asset Management’s Regenxbio RGNX Stock Holding History

Tyers Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$134K	Buy	3,760 +272	+8%	+$11K	﹤0.01%	792
2019 Q2	$179K	Hold	3,488	–	–	0.01%	756
2019 Q1	$200K	Buy	3,488 +224	+7%	+$11.1K	0.01%	715
2018 Q4	$137K	Buy	3,264 +592	+22%	+$34.7K	0.01%	760
2018 Q3	$202K	Buy	2,672 +1,552	+139%	+$112K	0.01%	747
2018 Q2	$80K	Buy	+1,120	New	+$53.5K	﹤0.01%	875

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tyers Asset Management's RGNX Position: Q3 2019 in Review

Tyers Asset Management increased its Regenxbio (RGNX) stake by 7.8% in Q3 2019, buying an estimated $11K and bringing the position to 3,760 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #792.

Tyers Asset Management first reported a position in RGNX in Q2 2018 and has held it in 6 quarters since. The position peaked at $202K in Q3 2018. 168 funds tracked by Wall St. Rank hold RGNX as of Q3 2019.

Tyers Asset Management held 3,760 shares of Regenxbio worth $134K as of Q3 2019.
Tyers Asset Management bought 272 Regenxbio shares in Q3 2019, an estimated $11K.
Regenxbio made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #792 holding.
Tyers Asset Management first reported a position in Regenxbio in Q2 2018 and has held it in 6 quarters since.
Tyers Asset Management's Regenxbio position peaked at $202K in Q3 2018.
168 funds tracked by Wall St. Rank held Regenxbio as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.